Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Colman

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Journal of Neurosurgery|June 17, 2017
Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer DatabaseJonathan Frandsen, Andrew Orton, Randy Jensen, et al.
Neurosurgical Focus|March 3, 2015
A practical review of prognostic correlations of molecular biomarkers in glioblastomaMichael Karsy, Jayson A Neil, Jian Guan, et al.
Neuro-Oncology|October 26, 2013
Experimental validation of 5 in-silico predicted glioma biomarkersRheal A Towner, Randy L Jensen, Brian Vaillant, et al.
Cancer Research|November 16, 2014
Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cellsDimpy Koul, Jun Yao, Shuzhen Wan, et al.
Neurosurgical Focus|March 3, 2015
Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomasRicky Chen, Vijay M Ravindra, Adam L Cohen, et al.
Neurosurgery|July 24, 2010
Isolation and perivascular localization of mesenchymal stem cells from mouse brainSeok-Gu Kang, Naoki Shinojima, Anwar Hossain, et al.
Journal of Neuro-Oncology|December 15, 2025
Stereotactic radiosurgery for radiation‑induced meningiomas: long‑term institutional outcomes with patient- and lesion‑level analyses and an updated meta‑analysisSaachi Jhandi, Angad S Jhandi, Donald M Cannon, et al.
Plos One|April 21, 2015
Intermittent induction of HIF-1α produces lasting effects on malignant progression independent of its continued expressionHyunsung Choi, David L Gillespie, Shauna Berg, et al.
Neuro-Oncology Advances|May 27, 2024
D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomideWilliam B McKean, Jingye Yang, Kenneth Boucher, et al.
Cancer Research|March 16, 2013
Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cellsJun Fu, Dimpy Koul, Jun Yao, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Journal of Neurosurgery|June 17, 2017
Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer DatabaseJonathan Frandsen, Andrew Orton, Randy Jensen, et al.
Neurosurgical Focus|March 3, 2015
A practical review of prognostic correlations of molecular biomarkers in glioblastomaMichael Karsy, Jayson A Neil, Jian Guan, et al.
Neuro-Oncology|October 26, 2013
Experimental validation of 5 in-silico predicted glioma biomarkersRheal A Towner, Randy L Jensen, Brian Vaillant, et al.
Cancer Research|November 16, 2014
Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cellsDimpy Koul, Jun Yao, Shuzhen Wan, et al.
Neurosurgical Focus|March 3, 2015
Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomasRicky Chen, Vijay M Ravindra, Adam L Cohen, et al.
Neurosurgery|July 24, 2010
Isolation and perivascular localization of mesenchymal stem cells from mouse brainSeok-Gu Kang, Naoki Shinojima, Anwar Hossain, et al.
Journal of Neuro-Oncology|December 15, 2025
Stereotactic radiosurgery for radiation‑induced meningiomas: long‑term institutional outcomes with patient- and lesion‑level analyses and an updated meta‑analysisSaachi Jhandi, Angad S Jhandi, Donald M Cannon, et al.
Plos One|April 21, 2015
Intermittent induction of HIF-1α produces lasting effects on malignant progression independent of its continued expressionHyunsung Choi, David L Gillespie, Shauna Berg, et al.
Neuro-Oncology Advances|May 27, 2024
D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomideWilliam B McKean, Jingye Yang, Kenneth Boucher, et al.
Cancer Research|March 16, 2013
Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cellsJun Fu, Dimpy Koul, Jun Yao, et al.
Pageof 16